Zacks Research Has Bearish Estimate for McKesson Q2 Earnings

McKesson Co. (NYSE:MCK) – Research analysts at Zacks Research reduced their Q2 2025 EPS estimates for shares of McKesson in a research note issued to investors on Tuesday, October 22nd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $6.97 for the quarter, down from their prior estimate of $7.11. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Zacks Research also issued estimates for McKesson’s Q3 2025 earnings at $8.24 EPS, Q4 2025 earnings at $8.88 EPS, FY2025 earnings at $31.97 EPS, Q1 2026 earnings at $7.86 EPS, Q3 2026 earnings at $9.85 EPS and Q4 2026 earnings at $8.95 EPS.

A number of other equities research analysts also recently commented on the stock. Deutsche Bank Aktiengesellschaft cut their target price on shares of McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research report on Wednesday, September 25th. Leerink Partners reduced their price objective on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a research report on Monday, October 7th. Barclays raised their target price on McKesson from $596.00 to $616.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Evercore ISI cut their price target on McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Finally, Mizuho increased their price objective on shares of McKesson from $540.00 to $570.00 and gave the stock a “neutral” rating in a research note on Thursday, August 8th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $610.86.

McKesson Stock Down 0.7 %

Shares of MCK stock opened at $501.76 on Thursday. The firm has a market capitalization of $65.20 billion, a PE ratio of 22.42, a P/E/G ratio of 1.17 and a beta of 0.44. The company has a 50 day moving average price of $518.29 and a 200-day moving average price of $551.37. McKesson has a 52 week low of $431.35 and a 52 week high of $637.51.

McKesson (NYSE:MCK) last released its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The business had revenue of $79.28 billion during the quarter, compared to analyst estimates of $82.53 billion. McKesson had a net margin of 0.94% and a negative return on equity of 242.57%. McKesson’s revenue was up 6.4% compared to the same quarter last year. During the same period last year, the business earned $7.27 EPS.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of MCK. LRI Investments LLC purchased a new position in McKesson during the first quarter worth $28,000. Register Financial Advisors LLC purchased a new position in McKesson during the first quarter worth $29,000. Wolff Wiese Magana LLC lifted its position in shares of McKesson by 742.9% during the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after purchasing an additional 52 shares during the last quarter. ORG Wealth Partners LLC bought a new stake in shares of McKesson during the third quarter worth $40,000. Finally, ZRC Wealth Management LLC bought a new stake in shares of McKesson during the first quarter worth $48,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Brian S. Tyler sold 3,753 shares of McKesson stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $561.10, for a total transaction of $2,105,808.30. Following the sale, the chief executive officer now owns 78,586 shares in the company, valued at $44,094,604.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 0.11% of the company’s stock.

McKesson Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were given a dividend of $0.71 per share. The ex-dividend date was Friday, August 30th. This represents a $2.84 annualized dividend and a dividend yield of 0.57%. This is a boost from McKesson’s previous quarterly dividend of $0.62. McKesson’s dividend payout ratio (DPR) is presently 12.69%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.